Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
The Journal of Biological Chemistry|July 13, 2005
Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-RasNeesha Suvarna, Stephanie L Borgland, Jun Wang, et al.Chemmedchem|June 17, 2020
Evaluation of 5H-Thiazolo[3,2-α]pyrimidin-5-ones as Potential GluN2A PET TracersYingfang He, David M Whitehead, Emmanuelle Briard, et al.Chemmedchem|March 21, 2017
Improving Nonspecific Binding and Solubility: Bicycloalkyl Groups and Cubanes as para-Phenyl BioisosteresYves P Auberson, Cara Brocklehurst, Markus Furegati, et al.Molecular Pharmaceutics|July 28, 2021
Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [18F]PRIMATXMarcus Litchfield, Melinda Wuest, Daryl Glubrecht, et al.Science (New York, N.Y.)|May 15, 2004
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticityLidong Liu, Tak Pan Wong, Mario F Pozza, et al.Proceedings of the National Academy of Sciences of the United States of America|January 30, 2007
mGluR5 stimulates gliotransmission in the nucleus accumbensMarcello D'Ascenzo, Tommaso Fellin, Miho Terunuma, et al.ACS Chemical Neuroscience|April 25, 2013
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsOmar S Mabrouk, Flora Mela, Mariangela Calcagno, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 10, 2004
Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depressionPeter V Massey, Benjamin E Johnson, Peter R Moult, et al.Chembiochem : a European Journal of Chemical Biology|August 4, 2021
The Chemical Biology-Medicinal Chemistry Continuum: EFMC's VisionMaria Duca, Dennis Gillingham, Christian Adam Olsen, et al.Chimia|November 20, 2021
Fostering Research Synergies between Chemists in Swiss Academia and at NovartisArndt Meyer, Daniel Baeschlin, Cara E Brocklehurst, et al.Pageof 6